Literature DB >> 25215264

Functions of Antibodies.

Donald N Forthal1.   

Abstract

Entities:  

Year:  2014        PMID： 25215264      PMCID： PMC4159104     

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN： 2165-0497


× No keyword cloud information.
  267 in total

1.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection.

Authors:  Christopher J Bruno; Jeffrey M Jacobson
Journal:  J Antimicrob Chemother       Date:  2010-07-17       Impact factor: 5.790

3.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.

Authors:  Paul Gallo; Ricardo Gonçalves; David M Mosser
Journal:  Immunol Lett       Date:  2010-07-27       Impact factor: 3.685

4.  Neutralization of poliovirus by antibody-mediated polymerization.

Authors:  P Brioen; D Dekegel; A Boeyé
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

Review 5.  Importance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae.

Authors:  D Negrão-Corrêa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2001 Sep-Oct       Impact factor: 1.846

6.  Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.

Authors:  Emily J Platt; Michelle M Gomes; David Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

7.  Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

Authors:  Masanori Terajima; John Cruz; Mary Dawn T Co; Jane-Hwei Lee; Kaval Kaur; Jens Wrammert; Patrick C Wilson; Francis A Ennis
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

8.  Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

Authors:  Andrea Jegerlehner; Nicole Schmitz; Tazio Storni; Martin F Bachmann
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.

Authors:  Naotake Tsuboi; Kenichi Asano; Michael Lauterbach; Tanya N Mayadas
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

10.  Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.

Authors:  Thomas M Clausen; Stig Christoffersen; Madeleine Dahlbäck; Annette Eva Langkilde; Kamilla E Jensen; Mafalda Resende; Mette Ø Agerbæk; Daniel Andersen; Besim Berisha; Sisse B Ditlev; Vera V Pinto; Morten A Nielsen; Thor G Theander; Sine Larsen; Ali Salanti
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157
View more
  46 in total

1.  Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response.

Authors:  Stephanie Fischinger; Sally Shin; Carolyn M Boudreau; Margaret Ackerman; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jerome H Kim; Merlin L Robb; Nelson L Michael; Robert J O'Connell; Sandhya Vasan; Hendrik Streeck; Galit Alter
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 3.  Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Authors:  Malik R Seals; Monica M Moran; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 4.  N-Glycosylation and Inflammation; the Not-So-Sweet Relation.

Authors:  Barbara Radovani; Ivan Gudelj
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 5.  The role of actin and myosin in antigen extraction by B lymphocytes.

Authors:  Jia C Wang; John A Hammer
Journal:  Semin Cell Dev Biol       Date:  2019-12-18       Impact factor: 7.727

6.  Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis.

Authors:  Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 7.  Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.

Authors:  Hilal Ahmad Parray; Shivangi Shukla; Reshma Perween; Ritika Khatri; Tripti Shrivastava; Vanshika Singh; Praveenkumar Murugavelu; Shubbir Ahmed; Sweety Samal; Chandresh Sharma; Subrata Sinha; Kalpana Luthra; Rajesh Kumar
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-23       Impact factor: 5.560

Review 8.  A Glimpse into Uveitis in the Aging Eye: Pathophysiology, Clinical Presentation and Treatment Considerations.

Authors:  Elizabeth Akinsoji; Raquel Goldhardt; Anat Galor
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 4.271

9.  bbeaR: an R package and framework for epitope-specific antibody profiling.

Authors:  Maria Suprun; Randall J Ellis; Hugh A Sampson; Mayte Suárez-Fariñas
Journal:  Bioinformatics       Date:  2021-01-20       Impact factor: 6.937

10.  Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.

Authors:  Javier García-Abellán; Sergio Padilla; Marta Fernández-González; José A García; Vanesa Agulló; María Andreo; Sandra Ruiz; Antonio Galiana; Félix Gutiérrez; Mar Masiá
Journal:  J Clin Immunol       Date:  2021-07-17       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.